GovWire

Research: Valproate: review of safety data and expert advice on management of risks

Medicines Healthcare Products Regulatory Agency

November 28
16:30 2023

Valproate: review of safety data and expert advice on management of risks

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This report presents the MHRAs review of safety data for valproate in 2022 and expert advice on management of risks recommended by the CHM over multiple meetings. This report also presents the advice from the CHMs implementation Expert Working Group, which met several times in 2022 and 2023 and the changes their advice made to the introduction of these regulatory safety measures.

For more information see valproate document collection.

Published 28 November 2023

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: